drugset / Trial / NCT01651351
GLASSIA Infusion Rate Study
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study was to generate sufficient safety and tolerability information in support of an increase in the infusion rate of intravenous GLASSIA in the prescribing information from 0.04 to 0.2 mL/kg/min.
Timeline
- Start
- 2012-07-31
- Primary completion
- 2013-01-16
- Completion
- 2013-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alpha 1-Antitrypsin | Protein / enzyme biologic | — | Intravenous |